Malmö, Sweden

Payam Delfani

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Payam Delfani: Innovator in Pancreatic Cancer Diagnostics

Introduction

Payam Delfani is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in relation to pancreatic cancer. His innovative approach has the potential to improve early detection and treatment options for this challenging disease.

Latest Patents

Payam Delfani holds a patent titled "Methods, arrays and uses thereof." This invention provides a method for diagnosing or determining a pancreatic cancer-associated disease state. The method involves providing a sample from an individual and determining a biomarker signature by measuring the presence and/or amount of two or more biomarkers. The presence and/or amount of these biomarkers are indicative of the pancreatic cancer-associated disease state in the individual. This patent represents a significant advancement in the methods of diagnosing and treating pancreatic cancer, along with the development of arrays and kits for practical use.

Career Highlights

Payam Delfani is currently associated with Immunovia AB, a company focused on developing innovative diagnostic solutions. His work at Immunovia has allowed him to apply his expertise in biomarker research and cancer diagnostics. His contributions have been instrumental in advancing the company's mission to improve patient outcomes through early detection of diseases.

Collaborations

Payam has collaborated with several professionals in his field, including Linda Dexlin Mellby and Anders Carlsson. These collaborations have fostered a productive environment for innovation and research, enhancing the development of diagnostic methods and technologies.

Conclusion

Payam Delfani's work in pancreatic cancer diagnostics exemplifies the impact of innovation in healthcare. His patented methods and ongoing contributions to Immunovia AB highlight the importance of early detection in improving patient outcomes. His efforts continue to pave the way for advancements in cancer diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…